Table 2.
The baseline laboratory test results of all 67 study patients with COVID-19
| Assay (normal range) | All patients (n = 67 or specified) | Common patients (n = 64 or specified) | Severe patients (n = 3 or specified) |
|---|---|---|---|
| ALT (9–50 U/L) | 31.0 ± 31.6 | 30.3 ± 32.0 | 46.0 ± 17.0 |
| AST (15–40 U/L) | 29.0 ± 18.5 | 28.3 ± 18.6 | 45.0 ± 6.2 |
| ALP (45–125 U/L) | 79.8 ± 43.1 | 79.8 ± 44.0 | 79.3 ± 20.1 |
| GGT (10–60 U/L) | 37.3 ± 44.8 | 35.0 ± 42.3 | 86.7 ± 77.9 |
| ALB (40–55 g/L) | 41.5 ± 5.2 | 41.5 ± 5.3 | 40.8 ± 1.7 |
| TP (60–85 g/L) | 69.6 ± 5.8 | 69.6 ± 5.8 | 71.7 ± 5.2 |
| GLO (20–40 g/L) | 28.6 ± 3.9 | 28.5 ± 3.9 | 30.9 ± 3.7 |
| A/G (1.2–2.4) | 1.5 ± 0.2 | 1.5 ± 0.2 | 1.3 ± 0.1 |
| TBIL (0–23 μmol/L) | 9.1 ± 4.6 | 9.1 ± 4.6 | 9.8 ± 4.2 |
| IBIL (1.2–16 μmol/L) | 5.3 ± 3.2 | 5.3 ± 3.2 | 5.5 ± 3.0 |
| DBIL (0–8 μmol/L) | 3.8 ± 1.6 | 3.8 ± 1.6 | 4.3 ± 1.2 |
| TBA (0–10 μmol/L) | 6.8 ± 14.5 | 7.0 ± 14.8 | 3.5 ± 2.1 |
| PALB (0.2–0.43 g/L) | 0.2 ± 0.1 | 0.2 ± 0.1 | 0.1 ± 0.04 |
| CHE (4.62–11.5 KU/L) | 8.8 ± 2.0 | 8.8 ± 2.0 | 10.3 ± 1.3 |
| GLU (3.9–6.1 mmol/L) | 6.1 ± 1.3 | 6.1 ± 1.3 | 6.1 ± 0.7 |
| BUN (3.6–9.5 mmol/L) | 3.9 ± 1.0 | 4.0 ± 1.0 | 3.6 ± 0.8 |
| CREA (μmol /L) | 65.1 ± 11.0 | 65.3 ± 11.2 | 62.3 ± 4.9 |
| K+ (3.5–5.3 mmol/L) | 3.7 ± 0.4 | 3.8 ± 0.4 | 3.7 ± 0.2 |
| Na+ (137-147 mmol/L) | 138.9 ± 2.5 | 139.0 ± 2.4 | 136.6 ± 3.4 |
| CK (50–310 U/L) | 100.9 ± 115.4 | 88.8 ± 69.9 | 359.7 ± 424.5 |
| CK-MB (0–24 U/L) | 23.2 ± 19.9 | 22.6 ± 20.1 | 35.7 ± 13.3 |
| LDH (120–250 U/L) | 223.0 ± 68.4 | 215.6 ± 59.3 | 380.3 ± 68.5 |
| TG (0.56–1.7 mmol/L) | 1.3 ± 0.7 | 1.3 ± 0.7 | 1.46 ± 0.3 |
| CHO (3.1–5.2 mmol/L) | 4.2 ± 0.9 | 4.2 ± 0.9 | 4.5 ± 0.3 |
| HDL-C (1.03–3.0 mmol/L) | 1.0 ± 0.3 | 1.0 ± 0.3 | 1.0 ± 0.2 |
| LDL-C (2.1–3.12 mmol/L) | 2.7 ± 0.7 | 2.7 ± 0.8 | 3.1 ± 0.3 |
| CRP (0-6 mg/L) | 12.1 ± 19.3↑ | 9.8 ± 13.8↑ | 61.3 ± 50.2↑ |
| PT (10–13.5 s) | 11.0 ± 0.7 | 11.0 ± 0.7 | 11.0 ± 0.1 |
| PTA (70–140%) | 100.4 ± 10.0 | 100.4 ± 10.3 | 99.4 ± 1.4 |
| INR (0.85–1.15) | 1.0 ± 0.1 | 1.0 ± 0.1 | 1.0 ± 0.006 |
| aPTT (22–36 s) | 31.8 ± 4.4 | 31.5 ± 4.1 | 37.9 ± 8.5 |
| FIB (2.0–4.0 g/L) | 3.8 ± 2.6 | 3.8 ± 2.6 | 5.0 ± 0.7 |
| CT (14–21 s) | 16.9 ± 0.7 | 16.9 ± 0.7 | 16.6 ± 0.6 |
| D-Dimer (0–0.5μg/mL) | 0.3 ± 0.3 | 0.3 ± 0.4 | 0.3 ± 0.1 |
| WBC (3.5–9.5*10^9/L) | 4.7 ± 1.8 | 4.7 ± 1.8 | 4.4 ± 0.9 |
| Lymphocyte (1.1–3.2*10^9/L) | 1.4 ± 0.6 | 1.5 ± 0.6 | 0.9 ± 0.3 |
| Neutrophils (1.8–6.3*10^9/L) | 2.8 ± 1.4 | 2.7 ± 1.4 | 3.3 ± 0.8 |
| RBC (4.3–5.8*10^12/L) | 4.5 ± 0.5 | 4.5 ± 0.5 | 4.9 ± 0.5 |
| Hgb (130–175 g/L) | 135.1 ± 16.9 | 134.7 ± 17.0 | 145.0 ± 12.8 |
| HCT (40–50%) | 39.4 ± 4.2 | 39.3 ± 4.2 | 42.7 ± 2.6 |
| Platelets (125–350*10^9/L) | 194.8 ± 71.9 | 197.4 ± 72.1 | 139.7 ± 46.5 |
| Blood PH (7.350–7.450) | 7.4 ± 0.03(n = 62) | 7.4 ± 0.03 (n = 59) | 7.4 ± 0.008 |
| pO2 (80–100 mmHg) | 105.8 ± 27.8(n = 62) | 106.6 ± 27.6(n = 59) ↑ | 89.8 ± 33.5 |
| pCO2 (35–45 mmHg) | 39.2 ± 3.4(n = 62) | 39.3 ± 3.4(n = 59) | 36.4 ± 1.2 |
| sO2 (91.9–99.0%) | 97.4 ± 1.8(n = 62) | 97.5 ± 1.6(n = 59) | 94.8 ± 3.7 |
| HCO3−(21-27 mmol/L) | 24.5 ± 2.0(n = 62) | 24.5 ± 2.1 (n = 59) | 23.7 ± 0.4 |
| AG (8–16 mmol/L) | 10.9 ± 2.2(n = 62) | 11.0 ± 2.2 (n = 59) | 10.5 ± 2.2 |
| Lac (0.5–1.7 mmol/L) | 1.7 ± 0.6(n = 62) | 1.7 ± 0.6(n = 59) | 1.7 ± 0.6 |
| PCT (< 0.5 ng/ml) | 0.2 ± 0.08 (n = 56) | 0.2 ± 0.08(n = 54) | 0.24 ± 0 (n = 2) |
| BNP (0–100.0 pg/ml) | 12.2 ± 6.4 (n = 59) | 12.3 ± 6.5 (n = 56) | 10.0 ± 0 |
| cTnI (0.00–0.08 ng/ml) | 0.004 ± 0.007 (n = 60) | 0.004 ± 0.008 (n = 57) | 0.003 ± 0.002 |
| CD3 (690–1760/ul) | 1088.3 ± 451.8 (n = 46) | 1101.2 ± 448.3 (n = 45) | 509 (n = 1) |
| CD4 (410–884/ul) | 621.2 ± 287.1 (n = 46) | 627.0 ± 287.6 (n = 45) | 357 (n = 1) |
| CD8 (190–658/ul) | 384.9 ± 182.1(n = 46) | 390.4 ± 180.2 (n = 45) | 135 (n = 1) |
| NK cells (90–536/ul) | 339.4 ± 175.5(n = 46) | 339.8 ± 177.5 (n = 45) | 324(n = 1) |
| CD19 (90–323/ul) | 211.2 ± 187.9(n = 46) | 212.6 ± 189.8 (n = 45) | 145(n = 1) |
Data are expressed as mean ± standard deviation
Abbreviation: ALT the Alanine Aminotransferase test, AST the aspartate aminotransferase test, ALP the alkaline phosphatase test, GGT the gamma-glutamyl transpeptidase test, ALB the albumin test, TP the total protein test, GLO Globulin test, A/G the albumin globulin ratio, TBIL the total bilirubin test, IBIL the indirect bilirubin, DBIL the direct bilirubin test, TBA the thiobarbituric acid test, PALB the partner and localizer of BRCA2, CHE the cholinesterase test, GLU the blood glucose test, BUN the blood urea nitrogen test, CREA the creatinine blood test, K+ the potassium blood test, Na+ the sodium blood test, CK the creatine kinase blood test, CK-MB creatine kinase myocardial band, LDH the lactate dehydrogenase, TG Triglycerides, CHO Cholesterol, HDL-C High-density lipoprotein cholesterol, LDL-C the low-density lipoprotein cholesterol test, CRP C-reactive protein, PT the prothrombin time, PTA the pure-tone audiogram, INR International normalized ratio test, aPTT the activated partial thromboplastin time, FIB (fibrinogen) CT clotting time, WBC white blood cell, RBC red blood cell, Hgb the hemoglobin, HCT the hematocrit blood test, pO2 Partial Pressure of Oxygen, pCO2 the partial pressure of carbon dioxide, sO2 oxygen saturation, HCO3 bicarbonate test, AG the anion gap, Lac the lactic acid blood test, PCT procalcitonin, BNP Brain natriuretic peptide, cTnI the troponin test, CD cluster of differentiation, NK cells Natural killer cells, SD standard deviation
Note: ↑ means the test results were above normal